Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.37 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 4/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22032153 | 0.98 | ALDH1A1 (0.41) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL22032134 | 0.94 | CYP19A1 (0.40) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL28855491 | 0.87 | PTGER4 (0.36) | ALDH1A1KDM4EGAAMAPTHPGD | |
| SCHEMBL28855533 | 0.79 | KCNH3 (0.35) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL20439755 | 0.79 | IDO1 (0.38) | ALDH1A1KDM4EGAAMAPTPTGER4 | |
| SCHEMBL28855498 | 0.78 | PTGER4 (0.39) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL30620316 | 0.78 | MAPT (0.34) | MAPTPTGER4 | |
| SCHEMBL22084295 | 0.78 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL31162954 | 0.76 | GSTM2 (0.48) | ALDH1A1KDM4EMAPTHPGDTSHR | |
| SCHEMBL30159346 | 0.75 | L3MBTL1 (0.40) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688779-A2 | NOVEL COMPOUNDS AND USES THEREOF | Acelink Therapeutics, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211244-A2 | NOVEL COMPOUNDS AND USES THEREOF | ACELINK THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |